Efficacy of Smartphone Applications for Smoking Cessation: A Randomized Clinical Trial.

ABSTRACT:

Importance

Smoking is a leading cause of premature death globally. Smartphone applications for smoking cessation are ubiquitous and address barriers to accessing traditional treatments, yet there is limited evidence for their efficacy.

Objective

To determine the efficacy of a smartphone application for smoking cessation based on acceptance and commitment therapy (ACT) vs a National Cancer Institute smoking cessation application based on US clinical practice guidelines (USCPG).

Design, setting, and participants

A 2-group, stratified, double-blind, individually randomized clinical trial was conducted from May 27, 2017, to September 28, 2018, among 2415 adult cigarette smokers (n = 1214 for the ACT-based smoking cessation application group and n = 1201 for the USCPG-base

SUBMITTER: Bricker JB 

PROVIDER: S-EPMC7506605 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature